Influence of absorption promoters on pulmonary insulin bioactivity

AAPS PharmSciTech

Volumn 4, Issue 2, 2003, Pages

  Kumar, T Mahesh ^a   Misra, Ambikanandan ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Blood glucose reduction; Combination of absorption promoters; Insulin; Pharmacodynamics; Relative pulmonary bioactivity

Indexed keywords

BESTATIN; CHYMOSTATIN; GLUCOSE; INSULIN; OCTANOIC ACID; OLEIC ACID; PHOSPHATE; SODIUM; SORBITAN TRIOLEATE; TAUROGLYCOCHOLIC ACID; ANTIDIABETIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG DOSE REGIMEN; DRUG FORMULATION; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; MALE; NONHUMAN; PH; PHARMACODYNAMICS; RAT; ABSORPTION; ANIMAL; BIOAVAILABILITY; BLOOD; CHEMISTRY; DRUG EFFECT; SUBCUTANEOUS DRUG ADMINISTRATION;

ABSORPTION; ANIMALS; BIOLOGICAL AVAILABILITY; BLOOD GLUCOSE; CHEMISTRY, PHARMACEUTICAL; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; RATS;

EID: 0141541795     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt040215     Document Type: Article

References (35)

1. Jiang G, Qiu W, DeLuca PP. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres. Pharm Res. 2003;20:452-459.
2. Hildebrand GE, Tack JW. Microencapsulation of peptides and proteins. Int J Pharm. 2000;196:173-176.
3. Haeckel S, Sachse S, Albayrak C, Müller RH. Preparation and characterization of insulin-loaded microcapsules produced by the induced phase separation method. In: Proceedings of the World Meeting, 1998 APGI/APV, Paris.
4. Wall DA. Pulmonary absorption of peptides and proteins. Drug Deliv. 1995;2:1-20.
5. Stanley SD. Delivery of peptide and non-peptide drugs through the respiratory tract. Pharm Sci Tech Today. 1999;12:450-459.
6. Niven RW. Delivery of biotherapeutics by inhalation aerosol. Crit Rev Ther Drug Carrier Syst. 1995;12:151-231.
7. Patton JS, Trinchero P, Platz RM. Bioavailability of pulmonary delivered peptide and protein: interferon alpha, calcitonin and parathyroid hormones. J Control Release. 1994;28:79-85.
8. Edwards DA, Hanes J, Caponetti G, et al. Large porous particles for pulmonary drug delivery. Science. 1997;276:1868-1871.
9. Berelowitz M, Becker G. Inhaled insulin: clinical pharmacology and clinical study results. Respir Drug Deliv. 2000;7:151-154.
10. Clauson PG, Balent B, Okikawa J, et al. PK-PD of four different doses of pulmonary insulin delivered with AERx Diabetes management system. Respir Drug Deliv. 2000;7:155-161.
11. Adjei A, Hui J, Finley R, Lin T, Fort F. Pulmonary bioavailability of leuprolide acetate following multiple dosing to beagle dogs: some pharmacokinetic and pre-clinical issues. Int J Pharm. 1994;107:57-66.
12. Garber RA, Cappelleri JC, Kourides IA, Gelgend RA, Chandler LP, Gorkin L. Improved patient satisfaction with inhaled insulin in subjects with Type I diabetes mellitus: results from a multi-center randomized controlled trial. Diabetes. 1999;48(Suppl 1):A13.
13. Shyler JS, Cefalu IA, Landschulz WH, Balagtas CC, Cheng S-L, Gelfand RA. Efficacy of inhaled insulin in Type 1 diabetes. Lancet. 2002:357:331-335.
14. Fukuda Y, Tsuji T, Fujita T, Yamamoto A, Muranishi S. Susceptibility of insulin to proteolysis in rat lung homogenate and its protection from proteolysis by various protease inhibitors. Biol Pharm Bull. 1995;18:891-894.
15. Suarez S, Garcia L, Sarubbi D, et al. Facilitation of pulmonary insulin absorption by H-MAP: pharmacokinetics and pharmaco-dynamics in rats. Pharm Res. 2001;18:1677-1684.
16. Okumura K, Iwakawa S, Yoshida T, Seki T, Komada F. Intra-tracheal delivery of insulin: absorption from solution and aerosol by rat lung. Int J Pharm. 1992:88:63-73.
17. Liu FY, Shao Z, Kildsig DO, Mitra AK. Pulmonary delivery of free and liposomal insulin. Pharm Res. 1993;10:223-232.
18. Enna SJ, Schanker LS. Absorption of saccharides and urea from the rat lung. Am J Physiol. 1972;222:409-414.
19. Hyvärinen A, Nikkilä EA. Specific determination of blood glucose with o-toluidine. Clin Chim Acta. 1962;7:142-143.
20. Gibaldi M, Perri D. Pharmacokinetics. 2nd ed. New York, NY: Marcel Dekker; 1982.
21. Devore JL, Farnum NR. Applied Statistics for Engineers and Scientists. Pacific Grove, CA: Brooks/Cole Publishing Co;1999:394-398.
22. Brange J, Anderson L, Laursen ED, Meyn G, Resmussen E. Towards understanding insulin fibrillation. J Pharm Sci. 1997:86:517-524.
23. Brange J, Langkjaer L. Chemical stability of insulin, III: influence of excipients, formulation, and pH. Acta Pharm Nord. 1992;4:149-158.
24. Hirai S, Ikenaga T, Matsuzawa T. Nasal absorption of insulin in dogs. Diabetes. 1978;27:296-299.
25. Hirai S, Yashiki T, Mima H. Effect of surfactants on the nasal absorption in rats. Int J Pharm. 1981;9:165-172.
26. Gordon GS, Moses AC, Silver RD, Flier JS, Carey MC. Nasal absorption of insulin enhancement by bile salts. Proc Natl Acad Sci USA. 1985;82:7419-7423.
27. McMartin C, Hutchinson LEF, Hyde R, Peters GE. Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity. J Pharm Sci. 1987;70:535-540.
28. Yamomoto A, Hayakawa E, Lee HL. Insulin and pro-insulin proteolysis in mucosal homogenate of the albino rabbit: implications in peptide delivery from non-oral routes. Life Sci. 1990;47:2465-2474.
29. Khan MJ, Lakshminarayanaiah N, Trotman BW, Chun P, Kaplan SA, Margulies C. Calcium binding and bile salt structure. Hepatology. 1982;2:732.
30. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. Cell adhesion, cell junctions and the extracellular matrix. In: Molecular Biology of the Cell, 2nd edition. New York, Garland Publishing Inc. 1989;791-836.
31. Patton JS, Bukar J, Nagarajan S. Inhaled insulin. Adv Drug Deliv Rev. 1999;35:235-247.
32. Hooper NM. Ectopeptidases. In: Audus KL, Raub TJ, eds. Biological Barriers to Protein Drug Delivery. Pharmaceutical Biotechnology, Vol 4. New York, NY: Kluwer Academic/Plenum Publishers; 1993;23-50.
33. Takeyama M, Ishida T, Kokubu N, et al. Enhanced bioavailability of subcutaneously injected insulin by pretreatment with ointment containing protease inhibitors. Pharm Res. 1991;8:60-64.
34. Okumura K, Komada F, Ryohei H. Fate of porcine and human insulin at the subcutaneous injection site, I: degradation and absorption of insulin in the rat. J Pharmacobiodyn. 1985;8:25-32.
35. Hochman J, Artursson P. Mechanism of absorption enhancement and tight junction regulation. J Control Release. 1994;29:253-267.